Cargando…

Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors

OBJECTIVES: To determine the role of academic authors, funders, and contract research organisations in industry funded trials of vaccines, drugs, and devices and to determine lead academic authors’ experiences with industry funder collaborations. DESIGN: Cross sectional analysis of trial publication...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Kristine, Bero, Lisa, Redberg, Rita, Gøtzsche, Peter C, Lundh, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169401/
https://www.ncbi.nlm.nih.gov/pubmed/30282703
http://dx.doi.org/10.1136/bmj.k3654
_version_ 1783360511835897856
author Rasmussen, Kristine
Bero, Lisa
Redberg, Rita
Gøtzsche, Peter C
Lundh, Andreas
author_facet Rasmussen, Kristine
Bero, Lisa
Redberg, Rita
Gøtzsche, Peter C
Lundh, Andreas
author_sort Rasmussen, Kristine
collection PubMed
description OBJECTIVES: To determine the role of academic authors, funders, and contract research organisations in industry funded trials of vaccines, drugs, and devices and to determine lead academic authors’ experiences with industry funder collaborations. DESIGN: Cross sectional analysis of trial publications and survey of lead academic authors. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: The most recent 200 phase III and IV trials of vaccines, drugs, and devices with full industry funding, at least one academic author, published in one of the top seven high impact general medical journals (New England Journal of Medicine, Lancet, JAMA, BMJ, Annals of Internal Medicine, JAMA Internal Medicine, and PLoS Medicine). RESULTS: Employees of industry funders co-authored 173 (87%) of publications; 183 (92%) trials reported involvement of funders in design, and 167 (84%) reported involvement of academic authors. Data analysis involved the funder in 146 (73%) trials and the academic authors in 79 (40%). Trial reporting involved the funder in 173 (87%) trials and academic authors in 197 (99%). Contract research organisations were involved in the reporting of 123 (62%) trials. Eighty (40%) of 200 lead academic authors responded to the survey. Twenty nine (33%) of the 80 responders reported that academics had final say on the design. Ten responders described involvement of an unnamed funder and/or contract research organisation employee in the data analysis and/or reporting. Most academic authors found the collaboration with industry funder beneficial, but 3 (4%) experienced delay in publication due to the industry funder and 9 (11%) reported disagreements with the industry funder, mostly concerning trial design and reporting. CONCLUSIONS: Industry employees and academic authors are involved in the design, conduct, and reporting of most industry funded trials in high impact journals. However, data analysis is often conducted without academic involvement. Academics view the collaboration as beneficial, but some report loss of academic freedom.
format Online
Article
Text
id pubmed-6169401
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-61694012018-10-10 Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors Rasmussen, Kristine Bero, Lisa Redberg, Rita Gøtzsche, Peter C Lundh, Andreas BMJ Research OBJECTIVES: To determine the role of academic authors, funders, and contract research organisations in industry funded trials of vaccines, drugs, and devices and to determine lead academic authors’ experiences with industry funder collaborations. DESIGN: Cross sectional analysis of trial publications and survey of lead academic authors. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: The most recent 200 phase III and IV trials of vaccines, drugs, and devices with full industry funding, at least one academic author, published in one of the top seven high impact general medical journals (New England Journal of Medicine, Lancet, JAMA, BMJ, Annals of Internal Medicine, JAMA Internal Medicine, and PLoS Medicine). RESULTS: Employees of industry funders co-authored 173 (87%) of publications; 183 (92%) trials reported involvement of funders in design, and 167 (84%) reported involvement of academic authors. Data analysis involved the funder in 146 (73%) trials and the academic authors in 79 (40%). Trial reporting involved the funder in 173 (87%) trials and academic authors in 197 (99%). Contract research organisations were involved in the reporting of 123 (62%) trials. Eighty (40%) of 200 lead academic authors responded to the survey. Twenty nine (33%) of the 80 responders reported that academics had final say on the design. Ten responders described involvement of an unnamed funder and/or contract research organisation employee in the data analysis and/or reporting. Most academic authors found the collaboration with industry funder beneficial, but 3 (4%) experienced delay in publication due to the industry funder and 9 (11%) reported disagreements with the industry funder, mostly concerning trial design and reporting. CONCLUSIONS: Industry employees and academic authors are involved in the design, conduct, and reporting of most industry funded trials in high impact journals. However, data analysis is often conducted without academic involvement. Academics view the collaboration as beneficial, but some report loss of academic freedom. BMJ Publishing Group Ltd. 2018-10-03 /pmc/articles/PMC6169401/ /pubmed/30282703 http://dx.doi.org/10.1136/bmj.k3654 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Rasmussen, Kristine
Bero, Lisa
Redberg, Rita
Gøtzsche, Peter C
Lundh, Andreas
Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
title Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
title_full Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
title_fullStr Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
title_full_unstemmed Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
title_short Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
title_sort collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169401/
https://www.ncbi.nlm.nih.gov/pubmed/30282703
http://dx.doi.org/10.1136/bmj.k3654
work_keys_str_mv AT rasmussenkristine collaborationbetweenacademicsandindustryinclinicaltrialscrosssectionalstudyofpublicationsandsurveyofleadacademicauthors
AT berolisa collaborationbetweenacademicsandindustryinclinicaltrialscrosssectionalstudyofpublicationsandsurveyofleadacademicauthors
AT redbergrita collaborationbetweenacademicsandindustryinclinicaltrialscrosssectionalstudyofpublicationsandsurveyofleadacademicauthors
AT gøtzschepeterc collaborationbetweenacademicsandindustryinclinicaltrialscrosssectionalstudyofpublicationsandsurveyofleadacademicauthors
AT lundhandreas collaborationbetweenacademicsandindustryinclinicaltrialscrosssectionalstudyofpublicationsandsurveyofleadacademicauthors